These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 32677746)

  • 1. Apolipoprotein C-III O-glycoform profiling of 500 serum samples by matrix-assisted laser desorption/ionization mass spectrometry for diagnosis of congenital disorders of glycosylation.
    Wada Y; Okamoto N
    J Mass Spectrom; 2021 Apr; 56(4):e4597. PubMed ID: 32677746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. MALDI-MS profiling of serum O-glycosylation and N-glycosylation in COG5-CDG.
    Palmigiano A; Bua RO; Barone R; Rymen D; Régal L; Deconinck N; Dionisi-Vici C; Fung CW; Garozzo D; Jaeken J; Sturiale L
    J Mass Spectrom; 2017 Jun; 52(6):372-377. PubMed ID: 28444691
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MALDI-TOF MS applied to apoC-III glycoforms of patients with congenital disorders affecting O-glycosylation. Comparison with two-dimensional electrophoresis.
    Yen-Nicolaÿ S; Boursier C; Rio M; Lefeber DJ; Pilon A; Seta N; Bruneel A
    Proteomics Clin Appl; 2015 Aug; 9(7-8):787-93. PubMed ID: 25641685
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasma N-glycan profiling by mass spectrometry for congenital disorders of glycosylation type II.
    Guillard M; Morava E; van Delft FL; Hague R; Körner C; Adamowicz M; Wevers RA; Lefeber DJ
    Clin Chem; 2011 Apr; 57(4):593-602. PubMed ID: 21273509
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Matrix-Assisted Laser Desorption/Ionization Mass Spectrometry to Detect Diagnostic Glycopeptide Markers of Congenital Disorders of Glycosylation.
    Wada Y
    Mass Spectrom (Tokyo); 2020; 9(1):A0084. PubMed ID: 32547898
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mass spectrometry of transferrin and apolipoprotein C-III for diagnosis and screening of congenital disorder of glycosylation.
    Wada Y
    Glycoconj J; 2016 Jun; 33(3):297-307. PubMed ID: 26873821
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Electrospray Ionization Mass Spectrometry of Apolipoprotein CIII to Evaluate
    Wada Y; Okamoto N
    Mass Spectrom (Tokyo); 2022; 11(1):A0104. PubMed ID: 36060528
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Relative quantification of plasma N-glycans in type II congenital disorder of glycosylation patients by mass spectrometry.
    Barbosa EA; Fontes NDC; Santos SCL; Lefeber DJ; Bloch C; Brum JM; Brand GD
    Clin Chim Acta; 2019 May; 492():102-113. PubMed ID: 30776362
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mass spectrometry of apolipoprotein C-III, a simple analytical method for mucin-type O-glycosylation and its application to an autosomal recessive cutis laxa type-2 (ARCL2) patient.
    Wada Y; Kadoya M; Okamoto N
    Glycobiology; 2012 Aug; 22(8):1140-4. PubMed ID: 22611120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glycosylation Analysis for Congenital Disorders of Glycosylation.
    Li X; Raihan MA; Reynoso FJ; He M
    Curr Protoc Hum Genet; 2015 Jul; 86():17.18.1-17.18.22. PubMed ID: 26132001
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mass spectrometry glycophenotype characterization of ALG2-CDG in Argentinean patients with a new genetic variant in homozygosis.
    Papazoglu GM; Cubilla M; Pereyra M; de Kremer RD; Pérez B; Sturiale L; Asteggiano CG
    Glycoconj J; 2021 Apr; 38(2):191-200. PubMed ID: 33644825
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Serum N-glycan and O-glycan analysis by mass spectrometry for diagnosis of congenital disorders of glycosylation.
    Xia B; Zhang W; Li X; Jiang R; Harper T; Liu R; Cummings RD; He M
    Anal Biochem; 2013 Nov; 442(2):178-85. PubMed ID: 23928051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The impact of mass spectrometry in the diagnosis of congenital disorders of glycosylation.
    Sturiale L; Barone R; Garozzo D
    J Inherit Metab Dis; 2011 Aug; 34(4):891-9. PubMed ID: 21384227
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis.
    Wopereis S; Grünewald S; Morava E; Penzien JM; Briones P; García-Silva MT; Demacker PN; Huijben KM; Wevers RA
    Clin Chem; 2003 Nov; 49(11):1839-45. PubMed ID: 14578315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transferrin and apolipoprotein C-III isofocusing are complementary in the diagnosis of N- and O-glycan biosynthesis defects.
    Wopereis S; Grünewald S; Huijben KM; Morava E; Mollicone R; van Engelen BG; Lefeber DJ; Wevers RA
    Clin Chem; 2007 Feb; 53(2):180-7. PubMed ID: 17170056
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Complementarity of electrophoretic, mass spectrometric, and gene sequencing techniques for the diagnosis and characterization of congenital disorders of glycosylation.
    Bruneel A; Cholet S; Drouin-Garraud V; Jacquemont ML; Cano A; Mégarbané A; Ruel C; Cheillan D; Dupré T; Vuillaumier-Barrot S; Seta N; Fenaille F
    Electrophoresis; 2018 Dec; 39(24):3123-3132. PubMed ID: 29869806
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Insights into complexity of congenital disorders of glycosylation.
    Goreta SS; Dabelic S; Dumic J
    Biochem Med (Zagreb); 2012; 22(2):156-70. PubMed ID: 22838182
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of new apolipoprotein-CIII glycoforms with ultrahigh resolution MALDI-FTICR mass spectrometry of human sera.
    Nicolardi S; van der Burgt YE; Dragan I; Hensbergen PJ; Deelder AM
    J Proteome Res; 2013 May; 12(5):2260-8. PubMed ID: 23527852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased Clinical Sensitivity and Specificity of Plasma Protein
    Chen J; Li X; Edmondson A; Meyers GD; Izumi K; Ackermann AM; Morava E; Ficicioglu C; Bennett MJ; He M
    Clin Chem; 2019 May; 65(5):653-663. PubMed ID: 30770376
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical and molecular diagnosis of non-phosphomannomutase 2 N-linked congenital disorders of glycosylation in Spain.
    Medrano C; Vega A; Navarrete R; Ecay MJ; Calvo R; Pascual SI; Ruiz-Pons M; Toledo L; García-Jiménez I; Arroyo I; Campo A; Couce ML; Domingo-Jiménez MR; García-Silva MT; González-Gutiérrez-Solana L; Hierro L; Martín-Hernández E; Martínez-Pardo M; Roldán S; Tomás M; Cabrera JC; Mártinez-Bugallo F; Martín-Viota L; Vitoria-Miñana I; Lefeber DJ; Girós ML; Serrano Gimare M; Ugarte M; Pérez B; Pérez-Cerdá C
    Clin Genet; 2019 May; 95(5):615-626. PubMed ID: 30653653
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.